GlassScriptPhysician profile
John D Schwerdt
NPI 1760706436
$13,395.76
in general payments reported to CMS, 2019-2025
39 companies · $2,297 in 2025
The $2,297 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $989 · 2021: $1,380 · 2022: $1,677 · 2023: $2,792 · 2024: $3,335 · 2025: $2,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,341 · Travel and Lodging: $769 · Consulting Fee: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,340.50 |
| Travel and Lodging | $768.78 |
| Consulting Fee | $315.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,455.99 | 2019-2025 | Valor, Dart-Fire, Citrefix |
| Smith+Nephew, INC. | $2,170.47 | 2019-2025 | Renasys Touch, Pico, Grafix Pl |
| Organogenesis INC. | $1,740.69 | 2019-2025 | Puraply Wound Matrix, Puraply, Affinity |
| Seapearl East, INC | $815.44 | 2020-2025 | |
| Paragon 28, INC. | $763.58 | 2021-2024 | Monkey Rings, Mini Monster, Precision Mis Bunion |
| Kci USA, INC. | $642.10 | 2019-2023 | V.A.C. Veraflo, V.A.C. Dermatac, Prevena |
| Paratek Pharmaceuticals, INC. | $507.00 | 2020-2025 | Nuzyra |
| Solventum Corporation | $412.16 | 2024 | 3m Skin and Nasal Antiseptic, V.A.C. Ats, Prevena |
| Treace Medical Concepts, INC. | $406.39 | 2024-2025 | |
| Reprise Biomedical, INC. | $360.82 | 2024-2025 | Miro3d, Miro 3d |
| Lifenet Health | $325.98 | 2023-2024 | Theragenesis Wound Matrix |
| Tactile Systems Technology INC | $325.83 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Becton, Dickinson and Company | $315.00 | 2023 | |
| Misonix INC | $272.17 | 2019-2021 | |
| Medtronic, INC. | $209.58 | 2022-2025 | In.Pact Admiral, Intellis Adaptivestim |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $189.45 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Advanced Oxygen Therapy INC. | $172.80 | 2022-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $162.60 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Amgen INC. | $140.00 | 2024 | Krystexxa |
| Bioventus LLC | $138.09 | 2019-2023 | |
| Abbott Laboratories | $136.30 | 2024 | Supera |
| Next Science LLC | $129.12 | 2023-2024 | Blastx, Xperience, Surgx |
| Trilliant Surgical LLC. | $76.21 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Convatec INC. | $73.40 | 2022-2025 | |
| Melinta Therapeutics, LLC | $65.66 | 2019 | |
| Bone Support INC. | $58.63 | 2025 | Cerament G, Ceramentbone Void Filler |
| Hydrofera LLC | $51.28 | 2023 | Hydrofera Blue |
| Merck Sharp & Dohme LLC | $48.79 | 2019 | |
| Averitas Pharma INC. | $37.86 | 2024 | Qutenza |
| Urgo Medical North America, LLC | $33.88 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Nalu Medical, INC. | $26.49 | 2022 | |
| Abbvie INC. | $23.13 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $20.15 | 2022 | |
| Mimedx Group, INC. | $18.18 | 2024 | |
| Axogen | $16.28 | 2019 | |
| Aroa Biosurgery Incorporated | $15.69 | 2022 | |
| Grt US Holding, INC. | $14.23 | 2022 | |
| Heron Therapeutics, INC. | $12.84 | 2021 | |
| Zimmer Biomet Holdings, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schwerdt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.